Morning Cortisol Elevations Linked to Frequent Cannabis Use, Oregon State University Study Finds

New research emerging from Oregon State University suggests that individuals who engage in frequent cannabis consumption begin their days with significantly elevated levels of cortisol compared to non-users. Published in the peer-reviewed journal Cannabis, the study highlights a potential association between regular cannabis intake and alterations in the human body’s intrinsic circadian stress rhythms. While millions of people turn to cannabis seeking temporary relief from daily pressures, this investigation underscores the complex and often misunderstood ways regular consumption interacts with human neurobiology over extended periods.

Led by Anita Cservenka, an associate professor in the Oregon State University College of Liberal Arts, the research team set out to explore the biological underpinnings of chronic cannabis habits. Stress remains one of the primary drivers self-reported by individuals who use cannabis, yet scientific understanding of how the plant alters the body’s long-term stress response systems remains incomplete. Cservenka and her colleagues, including fellow researchers Julia Donner and Alexia Obrochta, focused their inquiry on the hypothalamic-pituitary-adrenal (HPA) axis—the principal neuroendocrine feedback system that regulates stress, digestion, immune function, and mood.

The findings arrive against a backdrop of sweeping demographic and legal shifts regarding cannabis consumption across the United States. Over the past decade and a half, social acceptance and legalization have altered usage patterns, particularly among young adults. As the landscape of public health policy evolves, researchers emphasize the urgent need to understand the physiological consequences of rising consumption rates, moving past self-reported psychological benefits to examine hard biological markers.

Shifting Demographics and Escalating Usage Rates Among Young Adults

The release of the Oregon State University study coincides with a documented surge in cannabis use across the United States. Federal and academic surveys indicate that consumption patterns have transformed drastically since the early 2000s, driven by state-level legalizations, commercialization, and diminishing social stigmas.

Data compiled from national health surveys reveal that approximately 29 percent of young adults aged 19 to 30 report using cannabis within any given 30-day period. This prevalence rate has nearly doubled over the span of 15 years, indicating a profound shift in public habits. More concerning to public health officials is the escalation in frequency among this demographic. More than 10 percent of young adults now report using cannabis at least 20 times within a 30-day window, a frequency rate that is more than double the figures recorded a decade and a half ago.

This normalization of heavy use has transformed cannabis from an occasional recreational substance for many into a daily or near-daily habit. Consequently, scientists are racing to understand the cumulative physiological impact of chronic exposure to cannabinoids, particularly on the endocrine and nervous systems. Because the HPA axis is sensitive to chronic chemical inputs, researchers like Cservenka argue that examining physiological responses in heavy users is no longer optional, but rather a vital public health priority.

Understanding Cortisol and the Stress Awakening Response

To comprehend the significance of the Oregon State University findings, it is necessary to examine the physiological role of cortisol. Produced by the adrenal glands located just above the kidneys, cortisol is a steroid hormone that acts as a vital chemical messenger throughout the body. While colloquially branded as the "stress hormone" due to its rapid release during "fight or flight" situations, cortisol is essential for baseline human survival.

In normal physiological functioning, cortisol helps regulate blood pressure, maintain immune function, suppress inflammation, manage blood sugar levels, and control the sleep-wake cycle. Short-term spikes in cortisol enable individuals to navigate acute environmental threats or high-pressure situations by mobilizing energy stores and sharpening focus. However, when cortisol regulation is chronically disrupted, the consequences can be detrimental. Persistently elevated cortisol levels have been clinically linked to heightened risks of anxiety disorders, major depressive episodes, metabolic dysregulation, and cardiovascular disease.

The OSU research team centered its investigation on a specific physiological marker known as the cortisol awakening response (CAR). As Cservenka explains, CAR represents the sharp, predictable surge in cortisol that healthy human bodies produce immediately upon waking, typically reaching a peak approximately 30 minutes after an individual opens their eyes.

Researchers calculate CAR by collecting a baseline cortisol sample immediately upon waking, followed by a second sample 30 minutes later. The difference between these two measurements serves as an indicator of how well the body is preparing itself to meet the anticipated demands, stressors, and cognitive loads of the upcoming day.

In their analysis, Cservenka and her colleagues discovered that the magnitude of the morning cortisol increase—the actual rise between the first and second measurements—was largely comparable between frequent cannabis users and non-users. However, a profound divergence emerged at the very beginning of the cycle: individuals who used cannabis frequently already exhibited significantly higher baseline concentrations of cortisol in their systems at the exact moment of waking.

Methodological Nuances and Divergence from Prior Literature

While the findings provide a compelling window into the neurobiology of regular cannabis consumers, the study’s authors exercise rigorous scientific caution regarding causation. Cservenka is careful to emphasize that the cross-sectional design of the research does not establish a direct cause-and-effect relationship.

The data cannot conclusively prove that frequent cannabis use directly causes elevated morning cortisol levels, nor does it establish that individuals with naturally higher morning cortisol are inherently driven to consume cannabis more frequently to manage underlying stress. Resolving this chicken-and-egg dilemma will require longitudinal studies that track specific cohorts of individuals over extended periods, monitoring changes in their HPA axis functioning as their cannabis habits evolve or cease.

Furthermore, the OSU study’s results complicate an already intricate body of scientific literature regarding cannabis and the endocrine system. Earlier studies conducted by independent research groups frequently reported a "blunted" cortisol awakening response among regular cannabis users—meaning that their morning cortisol spikes were significantly suppressed compared to non-users.

The fact that the Oregon State University team observed elevated baseline levels rather than a blunted CAR highlights the complexity of neuroendocrine research. Cservenka notes that these discrepancies across studies likely stem from subtle variations in analytic strategies, participant characteristics, frequency thresholds defining "heavy use," and sample demographics. Such methodological differences underscore how difficult it is to isolate the precise physiological impacts of cannabis in human populations, where lifestyle factors, diet, sleep hygiene, and concurrent substance use can all influence endocrine health.

Potential Implications for Problematic Use and Stress Feedback Loops

Despite the need for further research, the discovery of elevated awakening cortisol among frequent users points to potential clinical applications. Cservenka suggests that morning cortisol concentrations could eventually be evaluated as a neurobiological marker of problematic cannabis use, helping clinicians identify individuals whose consumption patterns are beginning to negatively impact their physiological baseline.

This biological marker concept opens the door to understanding a potential feedback loop between chronic cannabis consumption and HPA axis dysregulation. If frequent cannabis use alters the body’s normal daily stress rhythms—leaving individuals with higher baseline stress hormones upon waking—those individuals may experience a subjective sense of heightened baseline stress or discomfort. Because cannabis is frequently utilized for its anxiolytic and relaxing properties, a poorly regulated stress system could paradoxically drive individuals back toward more frequent use to achieve temporary relief, thereby entrenching the habit further.

This self-medicating cycle poses challenges for addiction treatment and behavioral health interventions. If the physiological systems responsible for stress regulation are compromised by long-term substance use, individuals attempting to quit or moderate their consumption may experience amplified subjective stress during withdrawal or abstinence periods, complicating recovery efforts.

Future Directions in Neuroendocrine Research

As state-level legalization continues to expand and public perception of cannabis softens, the scientific community faces an imperative to separate cultural attitudes from biological realities. The Oregon State University study, funded by the OSU Center for the Humanities and the College of Liberal Arts, represents a foundational step in mapping the intricate biochemical pathways affected by cannabinoids.

Moving forward, researchers advocate for expanded, long-term funding to support comprehensive longitudinal studies. By tracking individuals from adolescence through early adulthood—the peak window for the onset of cannabis use—scientists hope to map the precise trajectory of HPA axis alterations over time. Such insights will be vital not only for individual clinical guidance, but also for shaping evidence-based public health messaging as a new generation navigates an increasingly accessible cannabis marketplace.